Medicine & Life Sciences

1. Kidney 100%
2. Transplant Recipients 95%
3. Transplants 94%
4. Tacrolimus 65%
5. Canada 48%
6. Cyclosporine 42%
7. Kidney Transplantation 42%
8. Chronic Kidney Failure 39%
9. Community Health Centers 36%
10. Ezetimibe 30%
11. Mycophenolic Acid 26%
12. Frailty 25%
13. Angiotensin Receptor Antagonists 25%
14. Organ Transplantation 24%
15. Acute Coronary Syndrome 22%
16. Hypercholesterolemia 22%
17. Angiotensin-Converting Enzyme Inhibitors 22%
18. Population 22%
19. Cardiovascular Diseases 21%
20. Multicenter Studies 20%
21. Chronic Renal Insufficiency 20%
22. Immunosuppression 20%
23. Evaluation Studies 20%
24. Allografts 19%
25. Atrophy 19%
26. Lipids 19%
27. Anemia 18%
28. Tissue and Organ Procurement 18%
29. Colorectal Neoplasms 17%
30. Prostatic Neoplasms 17%
31. Histology 17%
32. Mortality 17%
33. Outpatients 16%
34. Quality of Life 16%
35. Fibrosis 16%
36. LDL Cholesterol 14%
37. Therapeutic Equivalency 14%
38. Breast Neoplasms 14%
39. Prospective Studies 14%
40. Sirolimus 13%
41. Antihypertensive Agents 13%
42. Transplantation 13%
43. Reproducibility of Results 13%
44. Proportional Hazards Models 13%
45. Therapeutics 12%
46. Glomerular Filtration Rate 12%
47. Immunosuppressive Agents 11%
48. Confidence Intervals 11%
49. Pharmaceutical Preparations 11%
50. Anticholesteremic Agents 10%